DK0554414T3 - Fremgangsmåde til fremstilling af en underenhedsvaccine mod hundeparvovirus og andre beslægtede vira - Google Patents

Fremgangsmåde til fremstilling af en underenhedsvaccine mod hundeparvovirus og andre beslægtede vira

Info

Publication number
DK0554414T3
DK0554414T3 DK92908548T DK92908548T DK0554414T3 DK 0554414 T3 DK0554414 T3 DK 0554414T3 DK 92908548 T DK92908548 T DK 92908548T DK 92908548 T DK92908548 T DK 92908548T DK 0554414 T3 DK0554414 T3 DK 0554414T3
Authority
DK
Denmark
Prior art keywords
cpv
protein
related viruses
subunit vaccine
fplv
Prior art date
Application number
DK92908548T
Other languages
English (en)
Inventor
Valdes Elena Cortes
Alvarez Jose Ignacio Casal
Olmo Carmen Vela
Original Assignee
Inmunologia & Genetica Aplic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inmunologia & Genetica Aplic filed Critical Inmunologia & Genetica Aplic
Application granted granted Critical
Publication of DK0554414T3 publication Critical patent/DK0554414T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/818—Viral vaccine for canidae or mustelidae, e.g. dogs, foxes, minks

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DK92908548T 1991-03-26 1992-03-26 Fremgangsmåde til fremstilling af en underenhedsvaccine mod hundeparvovirus og andre beslægtede vira DK0554414T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES9100844A ES2026826A6 (es) 1991-03-26 1991-03-26 Procedimiento para la produccion de una vacuna subunidad contra el parvovirus canino y otros virus relacionados.
PCT/ES1992/000031 WO1992017205A1 (es) 1991-03-26 1992-03-26 Procedimiento para la produccion de una vacuna subunidad contra el parvovirus canino y otros virus relacionados

Publications (1)

Publication Number Publication Date
DK0554414T3 true DK0554414T3 (da) 1998-09-07

Family

ID=8271929

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92908548T DK0554414T3 (da) 1991-03-26 1992-03-26 Fremgangsmåde til fremstilling af en underenhedsvaccine mod hundeparvovirus og andre beslægtede vira

Country Status (8)

Country Link
US (1) US5882652A (da)
EP (1) EP0554414B1 (da)
AT (1) ATE161729T1 (da)
AU (1) AU1585092A (da)
DE (1) DE69223939T2 (da)
DK (1) DK0554414T3 (da)
ES (1) ES2026826A6 (da)
WO (1) WO1992017205A1 (da)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2113572A1 (en) * 1991-07-17 1993-02-04 Peter J. Walker Improved vaccine
ES2065254B1 (es) * 1993-01-23 1995-07-16 Inmunologia & Genetica Aplic Peptidos y vacunas sinteticas contra parvovirus canino y otros virus relacionados.
DE69415462T2 (de) * 1993-01-23 1999-07-15 Inmunologia Y Genetica Aplicada, S.A., Madrid Synthetischen peptiden und impfstoffe gegen parvovirus
US5885585A (en) * 1994-11-08 1999-03-23 Cornell Research Foundation, Inc. Attenuated canine parvovirus vaccine
US5814510A (en) * 1994-11-08 1998-09-29 Cornell Research Foundation, Inc. Attenuated canine parvovirus vaccine
DE69737231T2 (de) * 1996-04-19 2007-10-11 Merial Ltd. Impfung mit nukleinsäuren gegen parvovirus infektionen
US7556805B2 (en) 1996-12-10 2009-07-07 Sloan-Kettering Inststute for Cancer Research and The Animal Medical Center Compositions for treatment of melanoma and method of using same
US6328969B1 (en) 1996-12-10 2001-12-11 Sloan-Kettering Institute For Cancer Research Method and compositions for stimulation of an immune response to a differentiation antigen stimulated by an altered differentiation antigen
EP0863151A1 (en) * 1997-02-12 1998-09-09 Akzo Nobel N.V. "Canine parvovirus dna vaccines"
CA2223029A1 (en) 1997-02-12 1998-08-12 Akzo Nobel Nv Canine parvovirus dna vaccines
US8021666B2 (en) 1997-02-18 2011-09-20 Sloan-Kettering Institute For Cancer Research Method and compositions for stimulation of an immune response to CD20 using a xenogeneic CD20 antigen
CZ287956B6 (cs) * 1997-11-04 2001-03-14 Medipharm Cz, S. R. O. Perorální přípravek k prevenci a léčbě parvovirózy psů
US6238860B1 (en) 1998-11-05 2001-05-29 Dyax Corp. Binding moieties for human parvovirus B19
US6759237B1 (en) * 1998-11-05 2004-07-06 The Trustees Of The University Of Pennsylvania Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
ATE454445T1 (de) * 1998-11-10 2010-01-15 Univ North Carolina Virusvektoren und verfahren für ihre herstellung und verabreichung.
US20020045264A1 (en) * 2000-03-14 2002-04-18 During Matthew J. Production of chimeric capsid vectors
WO2006066066A2 (en) * 2004-12-15 2006-06-22 University Of North Carolina At Chapel Hill Chimeric vectors
EP1981548A4 (en) * 2006-01-20 2010-03-24 Univ North Carolina ENHANCED PRODUCTION OF INFECTIOUS VECTORS OF PARVOVIRUS IN INSECT CELLS
NZ599585A (en) * 2007-06-14 2013-12-20 Univ Oklahoma State Vaccines containing canine parvovirus genetic variants
US8227583B2 (en) 2007-06-14 2012-07-24 The Board Of Regents For Oklahoma State University Vaccines containing canine parvovirus genetic variants
CN102459578A (zh) * 2009-01-30 2012-05-16 俄克拉荷马州大学评议会 基于在北美狗中循环的犬瘟热病毒的免疫原性组合物、疫苗和诊断方法
WO2010093784A2 (en) 2009-02-11 2010-08-19 The University Of North Carolina At Chapel Hill Modified virus vectors and methods of making and using the same
JP2013507925A (ja) 2009-10-14 2013-03-07 ザ・ボード・オブ・リージェンツ・フォー・オクラホマ・ステート・ユニバーシティ アライグマからのイヌパルボウイルス−２に関連するウイルスの分離
US9169494B2 (en) 2010-01-12 2015-10-27 The University Of North Carolina At Chapel Hill Restrictive inverted terminal repeats for viral vectors
US9409953B2 (en) 2011-02-10 2016-08-09 The University Of North Carolina At Chapel Hill Viral vectors with modified transduction profiles and methods of making and using the same
JP6387350B2 (ja) 2012-09-28 2018-09-05 ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル 希突起神経膠細胞を標的とするアデノ随伴ウイルスベクター
DK2968605T3 (da) 2013-03-15 2022-09-26 Univ North Carolina Chapel Hill Fremgangsmåder og sammensætninger til dobbelte glycanbindende aav-vektorer
US9447433B2 (en) 2013-03-15 2016-09-20 The University Of North Carolina At Chapel Hill Synthetic adeno-associated virus inverted terminal repeats
CN104388394B (zh) * 2014-10-22 2017-03-15 中国农业科学院特产研究所 水貂细小病毒弱毒疫苗株及其在制备水貂细小病毒弱毒疫苗中的用途
EP4344741A2 (en) 2014-11-21 2024-04-03 The University of North Carolina at Chapel Hill Aav vectors targeted to the central nervous system
CA2972807C (en) 2015-01-14 2024-01-16 The University Of North Carolina At Chapel Hill Methods and compositions for targeted gene transfer
EP3253786A4 (en) 2015-02-06 2018-10-17 The University of North Carolina at Chapel Hill Optimized human clotting factor viii gene expression cassettes and their use
ES2865487T3 (es) 2015-09-28 2021-10-15 Univ North Carolina Chapel Hill Métodos y composiciones para vectores virales que evaden los anticuerpos
EP3449250B1 (en) 2016-04-28 2020-11-04 Indiana University Research & Technology Corporation Methods and compositions for resolving components of a virus preparation
AU2018234695A1 (en) 2017-03-15 2019-09-12 The University Of North Carolina At Chapel Hill Polyploid adeno-associated virus vectors and methods of making and using the same
WO2019060538A1 (en) 2017-09-20 2019-03-28 The Trustees Of Indiana University METHODS FOR LIPOPROTEIN RESOLUTION BY MASS SPECTROMETRY
CN107827958B (zh) * 2017-11-11 2020-08-25 中牧实业股份有限公司 犬细小病毒合成肽疫苗及其制备方法和应用
WO2019140233A1 (en) 2018-01-12 2019-07-18 The Trustees Of Indiana University Electrostatic linear ion trap design for charge detection mass spectrometry
MX2020010466A (es) 2018-04-03 2021-01-08 Vectores de virus que evitan anticuerpos.
BR112020020341A2 (pt) 2018-04-03 2021-01-05 Stridebio, Inc. Vetores de vírus direcionados a tecidos oftálmicos
CN112272672A (zh) 2018-04-03 2021-01-26 斯特里迪比奥公司 抗体逃避性病毒载体
CN112703579A (zh) 2018-06-04 2021-04-23 印地安纳大学理事会 用于高通量电荷检测质谱分析的离子阱阵列
AU2019281715B2 (en) 2018-06-04 2024-06-13 The Trustees Of Indiana University Apparatus and method for capturing ions in an electrostatic linear ion trap
WO2019236139A1 (en) 2018-06-04 2019-12-12 The Trustees Of Indiana University Interface for transporting ions from an atmospheric pressure environment to a low pressure environment
WO2019236143A1 (en) 2018-06-04 2019-12-12 The Trustees Of Indiana University Apparatus and method for calibrating or resetting a charge detector
WO2019236140A1 (en) 2018-06-04 2019-12-12 The Trustees Of Indiana University Charge detection mass spectrometry with real time analysis and signal optimization
JP7285023B2 (ja) 2018-11-20 2023-06-01 ザ・トラスティーズ・オブ・インディアナ・ユニバーシティー 単一粒子質量分光分析のためのオービトラップ
KR20210097731A (ko) 2018-12-03 2021-08-09 더 트러스티즈 오브 인디애나 유니버시티 정전 선형 이온 트랩을 이용하여 다수의 이온을 동시에 분석하기 위한 장치 및 방법
AR118465A1 (es) 2019-03-21 2021-10-06 Stridebio Inc Vectores de virus adenoasociados recombinantes
WO2020219527A1 (en) 2019-04-23 2020-10-29 The Trustees Of Indiana University Identification of sample subspecies based on particle charge behavior under structural change-inducing sample conditions
EP3959227A1 (en) 2019-04-26 2022-03-02 The University of North Carolina at Chapel Hill Methods and compositions for dual glycan binding aav2.5 vector
IL292297A (en) 2019-10-17 2022-06-01 Stridebio Inc Adeno-associated viral vectors for the treatment of Niemann-Pick type c disease
WO2022093769A1 (en) 2020-10-28 2022-05-05 The University Of North Carolina At Chapel Hill Methods and compositions for dual glycan binding aav2.5 vector
CA3196036A1 (en) 2020-10-28 2022-05-05 The University Of North Carolina At Chapel Hill Methods and compositions for dual glycan binding aav2.5 vector
CN112553168B (zh) * 2020-12-23 2022-03-08 江苏省农业科学院 分泌抗猫细小病毒vp2蛋白单克隆抗体的杂交瘤细胞3a6株及其应用
TW202242124A (zh) 2021-01-14 2022-11-01 美商史崔德生物公司 靶向ｔ細胞之ａａｖ載體
JP2024515626A (ja) 2021-04-16 2024-04-10 アスクレピオス バイオファーマシューティカル， インコーポレイテッド 血液脳関門を横断し低減された液性応答を惹起する合理的ポリプロイドａａｖビリオン
TW202342759A (zh) 2022-02-04 2023-11-01 美商史崔德生物公司 重組腺相關病毒載體及其使用方法
WO2024124019A2 (en) 2022-12-07 2024-06-13 Ginkgo Bioworks, Inc. Aav vectors targeting hematopoietic stem cells

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4193990A (en) * 1979-02-16 1980-03-18 Cornell Research Foundation, Inc. Heterotypic canine parvovirus vaccine
GB8508685D0 (en) * 1985-04-03 1985-05-09 Minor P D Peptides
AU7966987A (en) * 1986-09-08 1988-04-07 Applied Biotechnology, Inc. Empty viral capsid vaccines
US4870023A (en) * 1987-03-16 1989-09-26 American Biogenetic Sciences, Inc. Recombinant baculovirus occlusion bodies in vaccines and biological insecticides
US4971793A (en) * 1988-05-09 1990-11-20 Boyce Thompson Institute For Plant Research, Inc. Subunit canine parvovirus vaccine
EP0441897A4 (en) * 1988-11-14 1992-06-24 Us Health Parvovirus capsids
DE69415462T2 (de) * 1993-01-23 1999-07-15 Inmunologia Y Genetica Aplicada, S.A., Madrid Synthetischen peptiden und impfstoffe gegen parvovirus

Also Published As

Publication number Publication date
WO1992017205A1 (es) 1992-10-15
ATE161729T1 (de) 1998-01-15
EP0554414B1 (en) 1998-01-07
EP0554414A1 (en) 1993-08-11
US5882652A (en) 1999-03-16
AU1585092A (en) 1992-11-02
ES2026826A6 (es) 1992-05-01
DE69223939D1 (de) 1998-02-12
DE69223939T2 (de) 1998-07-09

Similar Documents

Publication Publication Date Title
DK0554414T3 (da) Fremgangsmåde til fremstilling af en underenhedsvaccine mod hundeparvovirus og andre beslægtede vira
DK0551449T3 (da) Fremgangsmåde til fremstilling af en underenhedsvaccine mod porcin parvovirus
Kamel et al. Foot-and-mouth disease vaccines: recent updates and future perspectives
McGettigan Experimental rabies vaccines for humans
JP2021182922A5 (da)
Fang et al. Enhanced immunogenicity of the modified GP5 of porcine reproductive and respiratory syndrome virus
JP6346143B2 (ja) 組換え弱毒化パルボウイルス
JP2018536433A5 (da)
KR920703831A (ko) 백신(vaccines)
JP2017530124A5 (da)
DK157087D0 (da) Multivalent vaccine, isaer herpesvirusvaccine, dens anvendelse og deri indgaaende virus
JPS63196293A (ja) 融合蛋白
JP2018515141A (ja) 新規のバキュロウイルスベクター及び使用の方法
RU2012119494A (ru) Выделение вируса, родственного парвовирусу-2 собак, от енота
Thomas et al. Evaluation of efficacy of mammalian and baculovirus expressed E2 subunit vaccine candidates to bovine viral diarrhoea virus
JP2021501757A (ja) 狂犬病ウイルスワクチン
Huang et al. Construction and immunogenicity of a recombinant pseudotype baculovirus expressing the glycoprotein of rabies virus in mice
Moreno et al. Recombinant Rift Valley fever viruses encoding bluetongue virus (BTV) antigens: Immunity and efficacy studies upon a BTV-4 challenge
JP6280635B2 (ja) 安定化ｆｍｄｖキャプシド
Hoshino et al. Serological comparison of canine rotavirus with various simian and human rotaviruses by plaque reduction neutralization and hemagglutination inhibition tests
JP2009544303A5 (da)
DE3685837D1 (de) Hepatitis-a-virus-impfstoff.
EP0485463B1 (en) Attenuated canine parvovirus (cpv), vaccine comprising cpv and method of preventing infection by cpv in dogs
Xiao et al. VP2 virus‐like particles elicit protective immunity against duckling short beak and dwarfism syndrome in ducks
CA2351010A1 (en) A broad spectrum infectious bursal disease virus vaccine